From: Postoperative intubation time is associated with acute kidney injury in cardiac surgical patients
 | No AKI N =419 | AKI N =165 | Significance |
---|---|---|---|
Age (years) | 67 (65 to 68) | 72 (71 to 73) | P <0.001 |
Male/female (%) | 272/147 (64.9/35.1) | 108/57 (65.5/34.5) | P =0.98 |
Height (cm) | 172 (170 to 173) | 170 (168 to 172) | P =0.02 |
Weight (kg) | 81 (80 to 84) | 80 (78 to 83) | P =0.62 |
Additive Euroscore | 4 (4 to 5) | 6 (5 to 7) | P <0.001 |
Preoperative creatinine (μmol/l) | 79 (77 to 82) | 87 (82 to 94) | P <0.001 |
Preoperative eGFR § (ml/min/1.73 m2) | 83.9 (80.5 to 86.2) | 72.6 (67.6 to 78.4) | P <0.001 |
Preoperative diuretics | Â | Â | Â |
Y/N | 227/192 | 103/62 | P =0.065 |
(%) | 54.2/ 45.8 | 62.4/37.6 | |
ScO2 air (%) | 63 (63 to 64) | 61 (60 to 62) | P <0.001 |
ScO2 ox (%) | 68 (67 to 69) | 67 (65 to 68) | P =0.005 |
ScO2 minox (%) | 62 (61 to 62) | 59 (57 to 61) | P <0.001 |
Preoperative LVEF | Â | Â | Â |
- good | 315 (75.1) | 122 (73.9) | P =0.63 |
- moderate | 88 (21) | 38 (23) | |
- poor | 16 (3.8) | 4 (2.4) | |
CABG | Â | Â | Â |
- no | 176 (42) | 43 (26.1) | P <0.001 |
- yes | 243 (58) | 122 (73.9) | |
Duration of CPB (min) | 110 (104 to 116) | 128 (118 to 140) | P <0.001 |
Duration of surgery | 245 (236 to 253) | 272 (265 to 288) | P <0.001 |
Minimal hematocrit (%) | 25 (25 to 26) | 25 (24 to 25) | P =0.002 |
Minimal temperature during CBP (°C) | 32 (32 to 32) | 32 (32 to 32) | P =0.48 |
Blood products (units) | 2 (1 to 2) | 3 (2 to 4) | P <0.001 |
Cristalloids (ml) | 4560 (4510 to 4640) | 4580 (4450 to 4710) | P =0.84 |
Colloids (ml) | 2000 (2000 to 2500) | 2500 (2000 to 2500) | P =0.08 |
Drainage loss (ml) | 800 (800 to 850) | 950 (900 to 1000) | P <0.001 |
Postoperative urine flow (ml/24 h) | 2930 (2869 to 3050) | 2450 (2198 to 2650) | P <0.001 |
Postoperative diuretics | Â | Â | Â |
Y/N | 381/38 | 145/20 | P =0.444 |
(%) | 90.9%/9.1% | 87.8%/12.2% | |
Maximal postoperative lactate (mmol/l) | 1.9 (1.7 to 1.9) | 2.4 (2.2 to 2.7) | P <0.001 |
MAP baseline (%) | 83 (82 to 85) | 85 (82 to 89) | P =0.32 |
MAP mean IOP (mmHg) | 71.7 (71.0 to 72.3) | 70.7 (69.5 to 71.7) | P =0.11 |
CVP mean IOP (mmHg) | 10.0 (9.3 to 10.3) | 10.7 (10.0 to 11.5) | P =0.006 |
ScvO2 mean IOP (%) | 81.5 (80.6 to 82.0) | 80.9 (79.2 to 82.7) | P =0.34 |
SvO2 mean IOP * (%) | 79.5 (78.5 to 80.7) | 79.3 (77.6 to 80.2) | P =0.74 |
PAP mean IOP * (mmHg) | 28.3 (23.5 to 26.2) | 26.9 (24.4 to 29.6) | P =0.01 |
CI mean IOP * (l/min/m2) | 2.9 (2.8 to 3.1) | 1.8 (2.6 to 3.0) | P =0.07 |
MAP mean POP (mmHg) | 75.2 (74.4 to 76.0) | 72.6 (71.6 to 74.2) | P <0.001 |
CVP mean POP (mmHg) | 14.7 (14.3 to 14.9) | 15.2 (14.8 to 16.2) | P <0.001 |
ScvO2 mean POP (%) | 70.6 (69.5 to 71.7) | 69.3 (66.4 to 71.3) | P =0.09 |
SvO2 mean POP * (%) | 68.4 (67.1 to 69.5) | 68.5 (66.5 to 70.4) | P =0.86 |
PAP mean POP * (mmHg) | 28.3 (27.6 to 29.2) | 30.4 (29.0 to 32.2) | P =0.03 |
RPP mean POP (mmHg) | 60.5 (59.9 to 61.4) | 57.4 (56.0 to 59.0) | P <0.001 |
CI mean POP * (l/min/m2) | 3.2 (3.0 to 3.3) | 3.0 (2.8 to 3.1) | P =0.006 |
Dobutamine - IOP (no. of pts. (%)) | Â | Â | P =0.03 |
0 | 195 (46.5) | 60 (36.4) | |
<15 mg/h | 93 (22.2) | 37 (22.4) | |
15 - 30 mg/h | 115 (27.4) | 54 (32.7) | |
>30 mg/h | 16 (3.8) | 14 (8.5) | |
Dobutamine - POP (no. of pts. (%)) | Â | Â | P <0.001 |
0 | 159 (37.9) | 40 (24.2) | |
<15 mg/h | 137 (32.7) | 47 (28.5) | |
15 - 30 mg/h | 107 (25.5) | 57 (34.5) | |
>30 mg/h | 16 (3.8) | 21 (12.7) | |
PDE - III - IOP (no. of pts. (%)) | Â | Â | P =0.001 |
0 | 258 (61.6) | 77 (46.7) | |
Low dose | 28 (6.7) | 7 (4.2) | |
Moderate dose | 124 (29.6) | 74 (44.8) | |
High dose | 10 (2.4) | 7 (4.2) | |
PDE III-I - POP (no. of pts. (%)) | Â | Â | P <0.001 |
0 | 216 (51.6) | 55 (33.3) | |
Low dose | 41 (9.8) | 19 (11.5) | |
Moderate dose | 145 (34.6) | 79 (47.9) | |
High dose | 16 (3.8) | 12 (7.3) | |
Noradrenaline - IOP (no. of pts. (%)) | Â | Â | P =0.054 |
0 | 51 (12.2) | 11 (6.7) | |
<0.3 mg/h | 192 (45.8) | 69 (41.8) | |
0.3 - 0.6 mg/h | 130 (31) | 57 (34.5) | |
<0.6 mg/h | 46 (10.9) | 28 (16.9) | |
Noradrenaline - POP (no. of pts. (%)) | Â | Â | P <0.001 |
0 | 72 (17.2) | 18 (10.9) | |
<0.3 mg/h | 205 (48.9) | 57 (34.5) | |
0.3 - 0.6 mg/h | 94 (22.4) | 47 (28.5) | |
<0.6 mg/h | 48 (11.5) | 43 (26.1) | |
Vasopressine - IOP (no. of pts. (%)) | Â | Â | P =0.016 |
0 | 393 (93.8) | 142 (86.1) | |
<3 U/h | 17 (4.1) | 16 (9.7) | |
3 - 6 Uh | 8 (1.9) | 7 (4.2) | |
>6 U/h | 1 (0.2) | 0 (0) | |
Vasopressine - POP (no. of pts. (%)) | Â | Â | P <0.001 |
0 | 384 (91.6) | 137 (83) | |
<3 U/h | 31 (7.4) | 17 (10.3) | |
3 - 6 Uh | 3 (0.7) | 7 (4.2) | |
> 6 U/h | 1 (0.2) | 4 (2.4) | |
Time to first extubation (h) | 7 (6 to 7) | 8 (7 to 9) | P <0.001 |
Reintubation | Â | Â | P <0.001 |
No | 409 (97.6) | 133 (80.6) | |
Yes | 9 (2.1) | 32 (19.4) | |
Total ventilation time (h) | 7 (6 to 7) | 9 (7.4 to 11) | P <0.001 |
Duration of ICU treatment (h) | 23 (22 to 23) | 66 (38 to 81) | P <0.001 |
Duration of HDU treatment (h) | 70 (65 to 77) | 124 (108 to 144) | P <0.001 |
Mortality 30 d (no. of pts. (%)) | 1 (0.2) | 10 (6.1) | P <0.001 |